Product Recalls in California

Product recalls affecting California — including food, drugs, consumer products, medical devices, and vehicles distributed to California. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 3,047 recalls have been distributed to California in the last 12 months.

56,506 total recalls
3,047 in last 12 months

Showing 48814900 of 13,703 recalls

DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Polyoxyl Lauryl Ether (Polidocanol) Injection Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2020· Spectrum Laboratory Products

Recalled Item: Ranitidine Hydrochloride (powder) Recalled by Spectrum Laboratory Products...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2020· Pharmaceutical Associates Inc

Recalled Item: Nystatin Oral Suspension Recalled by Pharmaceutical Associates Inc Due to...

The Issue: Subpotent: Out of specification for assay at the 12-month time point.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2020· Hikma Pharmaceuticals USA Inc.

Recalled Item: methylPREDNISolone Sodium Succinate For Injection Recalled by Hikma...

The Issue: Labeling: Incorrect Instructions: Vial label incorrectly instructs...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 10, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets Recalled by Lupin...

The Issue: CGMP Deviations: Out of specification test result observed during...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 10, 2020· PD-Rx Pharmaceuticals, Inc.

Recalled Item: ranitidine hydrochloride Recalled by PD-Rx Pharmaceuticals, Inc. Due to CGMP...

The Issue: CGMP Deviations: Received notice from supplier of potential...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 10, 2020· Advanced Accelerator Applications USA, Inc.

Recalled Item: NETSPOT Recalled by Advanced Accelerator Applications USA, Inc. Due to...

The Issue: Defective Container: loose aluminum cap crimp for the dilution buffer vial...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2020· AVKARE Inc.

Recalled Item: Dutasteride Capsules Recalled by AVKARE Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: High out of specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2020· Preferred Pharmaceuticals, Inc

Recalled Item: Preferred Pharmaceuticals Recalled by Preferred Pharmaceuticals, Inc Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2020· Preferred Pharmaceuticals, Inc

Recalled Item: Preferred Pharmaceuticals Recalled by Preferred Pharmaceuticals, Inc Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 6, 2020· H J Harkins Company Inc dba Pharma Pac

Recalled Item: Ranitidine Recalled by H J Harkins Company Inc dba Pharma Pac Due to CGMP...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 26, 2019· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: Chemical contamination; out of specification results obtained for equipment...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 26, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP...

The Issue: Failed Tablet/Capsule Specifications: Complaints related to crumbling of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 23, 2019· GSK Consumer Health, Inc

Recalled Item: Theraflu Cough Relief Recalled by GSK Consumer Health, Inc Due to Labeling:...

The Issue: Labeling: Label Lacks Warning: Product recalled due to absence of a warning...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: LIPO B 25MG/50MG/50MG/1000MCG/ML (10ML VIAL) in 20 mL syringe and Recalled...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BAC 160MCG/HYDROM 16MG/ML INJ in 20 mL syringe Assurance Infusion Recalled...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Denton Pharma, Inc.

Recalled Item: Ranitidine Tablets Recalled by Denton Pharma, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Taro Pharmaceuticals U.S.A., Inc.

Recalled Item: Lamotrigine Tablets Recalled by Taro Pharmaceuticals U.S.A., Inc. Due to...

The Issue: Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 20, 2019· Denton Pharma, Inc.

Recalled Item: Ranitidine Tablets Recalled by Denton Pharma, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 10MG/ FENT 1000MCG/ML INJ in 20 mL syringe Assurance Recalled by...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund